Provided are novel compounds represented by the following general formula [1] or pharmaceutically acceptable salts thereof, that inhibit LpxC, as well as pharmaceutical drugs comprising those compounds or pharmaceutically acceptable salts thereof, that exhibit antimicrobial activity against gram-negative bacteria including Pseudomonas aeruginosa and their drug resistant strains and are useful in the treatment of bacterial infections, wherein X is selected from the following formula [2] : Y is selected from the following formula [3].
Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System
申请人:Gupta Ajay
公开号:US20110319459A1
公开(公告)日:2011-12-29
Disclosed are compounds of the general formula (I):
TC
n
D (I),
compositions comprising an effective amount of said compounds either alone or in combination with other chemotherapeutic agents, and methods useful for treating or preventing cancer and for inhibiting tumour tissue growth. These compounds attenuate the oxidative damage associated with increased heme-oxygenase activity and can reduce cell proliferation in transformed cells. In addition, the described compounds and compositions are useful as neuroprotectants and for treating or preventing neurodegenerative disorders and other diseases of the central nervous system.